ArticleScientific reports2026
Synthesis, spectroscopic investigation, theoretical insights via DFT and biological assessment of some isatin-based metal complexes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Quantum Chemical Insights into Antibiotic Structure-Activity Relationships and Mechanisms of Action: A Review.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, new VO2+, Ni2+ and Cu2+ complexes (1–3), respectively, were synthesized from indoline-2,3-dione with 4,4′-diaminodiphenyl ether. The metal complexes were characterized using elemental analyses (C, H, and N), Fourier transform infrared (FT-IR), UV–Visible spectra, thermogravimetric analysis methods,1H-NMR spectrum, molar conductivity and magnetic susceptibility measurements. The findings showed a square pyramidal geometry around the VO2+ complex, tetrahedral and distorted square planar environments around the Ni2+ Cu2+ complexes. Density functional theory (DFT) calculations were performed to elucidate the geometrical and energetic properties of the ligand and its metal complexes. In vitro antidiabetic property of the synthesized ligand and its metal chelates (1–3) was estimated by α-amylase inhibition method. Investigating the compounds’ in vitro anticancer potential against the hepatic cancer cell lines (HepG-2) and against human lung fibroblast normal cell line (WI-38) was reported. The results showed that VO2+ complex possesses the highest ability to inhibit α-amylase as well as hepatic cancer cells. In light of this, VO2+ complex (1) that was synthesized has the potential to be utilized as possible candidates for antidiabetic and hepatic cancer treatment. The in-vitro antibacterial efficacy of the synthesized ligand and its metal complexes (1–3) was assessed against both two Gram-positive bacteria (B. subtilis and S. aureus) and two Gram-negative bacteria (E. coli and K. pneumonia). Cu2+ chelate showed the highest activity against the tested microbes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.